RTI Surgical Transforms Into Evergen, a Leading CDMO in Regenerative Medicine

UF startup RTI Surgical, a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, unveils its new corporate identity as Evergen, signaling its strategic evolution into a premier Contract Development and Manufacturing Organization (CDMO) providing biosolutions in regenerative medicine.

The rebranding follows a transformative year marked by the successful acquisitions of Cook Biotech and Collagen Solutions, establishing Evergen as the industry’s only CDMO offering a comprehensive portfolio of allograft and xenograft biomaterials at scale.

Read more about RTI Surgical Transforms Into Evergen, a Leading CDMO in Regenerative Medicine.